News | News By Subject | News by Disease News By Date | Search News

Thyroid cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Eisai Company (ESALY.PK) to Consider Legal Action in UK Cancer Drug Row     7/8/2016
AstraZeneca PLC (AZN) Halts Three Clinical Trial Programs, Reports Six Quarters of Top-line Growth     8/3/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Eisai Inc. (ESALF.PK)'s New Thyroid Cancer Drug Lenvatinib Shows Promise In Phase 3 Study     6/2/2014
Bay Area's Exelixis, Inc. (EXEL) Gets A Boost, Wins Approval For COMETRIQ® In European Union For Treatment Of MTC     3/27/2014
FDA Approves Bayer HealthCare (BAY), Onyx Pharmaceuticals, Inc. (ONXX)'s NEXAVAR® To Treat Type Of Thyroid Cancer     11/25/2013
Bayer AG (BAYN.DE) and Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Score FDA Priority Review as Thyroid Cancer Drug     8/27/2013
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Liver Cancer Drug Nexavar Slows Rare Thyroid Tumor     6/3/2013
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX) Drug Meets Goal in Thyroid Cancer Trial     1/3/2013
Exelixis, Inc. (EXEL)'s FDA Approves Cometriq to Treat Rare Type of Thyroid Cancer     12/3/2012
AstraZeneca PLC (AZN)'s Chemo Drug Caprelsa Works Against Thyroid Cancer in Phase II Trial     8/15/2012
EU Regulators Back AstraZeneca PLC (AZN) Thyroid Cancer Drug     11/18/2011
Exelixis, Inc. (EXEL)' Thyroid Cancer Drug Meets Primary Endpoint in Phase Trial     10/25/2011
FDA Approves AstraZeneca PLC (AZN)'s New Treatment for Rare Form of Thyroid Cancer     4/7/2011

News from Around the Web
Chamomile Tea Linked To Lower Thyroid Cancer Risk, Oxford University Study     4/22/2015
Fighting Cancer with Cancer: Mayo Clinic Finds Promising Use for Thyroid Cancer Gene     6/6/2011
With the Thyroid, Too Much or Too Little Sparks Trouble, University of Southern California Study     4/11/2011
Anxiety Over Radiation Drives a Sales Surge for Recipharm AB's Drug Against Thyroid Cancer     3/16/2011
100,000 Older People Missing Thyroid Treatment - Wolfson Institute Study     1/24/2011
Vandetanib Stalls Progression of Metastatic Medullary Thyroid Cancer, Stanford University Study     7/12/2010
Not All Thyroid Cancers Need Treatment, Veterans Affairs Medical Center Study     5/18/2010
Low-Dose Radiation Matches High-Dose in Thyroid Cancer, University of Toronto Study     6/17/2009
Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Study     5/18/2009
Supplement Hampers Thyroid Cancer Treatment, Memorial Sloan-Kettering Cancer Center Researcher Reports     1/22/2009
Researchers Discover Atomic Bomb Effect Results In Adult-Onset Thyroid Cancer, American Association for Cancer Research     8/29/2008
2 New Genes Tied To 3 Cancers; Finding Could Improve Early Detection Of Breast, Thyroid And Kidney Diseases, Cleveland Clinic Researchers Say     8/8/2008
Amgen (AMGN)'s (JOBS) Tumor-Starving Pill Helps Thyroid Cancer: M. D. Anderson Cancer Center Study     7/3/2008
Ohio State University Researchers Awarded $12M Grant to Study Thyroid Cancer     6/20/2008
Cosmetic Surgery Techniques Can Enhance Thyroid Surgery Results, Medical College of Georgia     7/9/2007

Press Releases
Interpace Diagnostics Launches Product Extension At World Conference On Thyroid Cancer     8/1/2017
Veracyte (VCYT) Announces Pivotal Clinical Validation Data For Afirma Genomic Sequencing Classifier Presented At World Congress On Thyroid Cancer     7/31/2017
Veracyte (VCYT) Announces Positive Data From Three Afirma Studies To Be Presented At World Congress On Thyroid Cancer     7/26/2017
Veracyte (VCYT) Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis     5/19/2017
Veracyte (VCYT) Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis     5/18/2017
Veracyte (VCYT) Announces Pivotal Clinical Validation Data For Next-Generation Afirma Test To Help More Patients Avoid Unnecessary Surgery In Thyroid Cancer Diagnosis     5/5/2017
Multiple Studies Presented At ENDO 2017 Support Use Of Veracyte (VCYT)'s Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis     4/4/2017
Blueprint Medicines (BPMC) Announces Enrollment Of First Patient In Phase 1 Clinical Trial For BLU-667     3/21/2017
Comeback Kid Exelixis (EXEL) Snags a $145 Million Deal With Drug Giant Takeda (TKPYY)     1/31/2017
Veracyte (VCYT) Announces New Data that Advance Understanding of the Role of Gene Alterations In Thyroid Cancer Diagnosis     5/27/2016
Eisai Inc. (ESALF.PK) To Present Analyses At 2016 ASCO Annual Meeting From Trials Supporting Recent FDA Approvals For The Company's Oncology Therapies     5/24/2016
New Study Supports Use Of Veracyte (VCYT)'s Medullary Thyroid Cancer Classifier As Part Of Its Comprehensive Afirma Solution     3/22/2016
Blueprint Medicines (BPMC) To Present Preclinical Data On RET Inhibitors In An Oral Presentation At AACR Annual Meeting     3/17/2016
Hutchison China MediTech (Chi-Med) Initiates Sulfatinib Phase II Clinical Trial In Thyroid Cancer     3/2/2016
Interpace Diagnostics Announces Agreement With America's Choice Provider Network To Cover All Of The Company's Molecular Tests For Thyroid And Pancreatic Cancer     3/1/2016